Bearish signal on daily chart
In the last 16 years, only 3.12 % trading sessions saw intraday declines higher than 5 % .
In the last 16 years, only 3.12 % trading sessions saw intraday declines higher than 5 % .
Company has spent 1.32% of its operating revenues towards interest expenses and 13.94% towards employee cost in the year ending Mar 31, 2020. (Source: Consolidated Financials)
5 day moving crossover appeared on Mar 04, 2021. Average price decline of -2.81% within 7 days of this signal in last 5 years.
Stock gave a 3 year return of 42.33% as compared to Nifty 100 which gave a return of 42.14%. (as of last trading session)
PE Ratio
This is a ratio arrived at by dividing the current market price of a stock by its latest (annual or annualized) earnings per share. Here we have taken the TTM (trailing twelve months) adjusted earnings per share.
EPS - TTM
Earnings per share (TTM) tells the profit after tax earned on a per share basis by a stock over the last twelve months or four quarters.
MCap
MCap or Market capitalization of a stock is calculated by multiplying the total number of shares outstanding of that particular stock with its current market price.
Sectoral MCap Rank
This is the ranking of a company within its sector based on MCap or Market capitalization. Higher the market capitalization of a company, higher the rank it is assigned.
PB Ratio
Price to Book represents the ratio of current market price of a stock to its book value per share. The book value itself is arrived at by dividing the net worth of a company by the total number of shares outstanding of the company at that time.
Dividend Yield
Dividend Yield calculates the amount of full year dividend declared by a company as a percentage of the current market price of a stock. All other things being equal, higher the dividend yield of the stock, the better it is for investors.
Face Value
Face value of a stock is the value ascribed to the stock as per the balance sheet of the company. The dividend declared by a company is usually declared as a percentage of face value.
Beta
1 Month | 1.73 |
3 Months | 1.31 |
6 Months | 0.82 |
1 Year | 1.06 |
3 Years | 1.23 |
VWAP
Volume Weighted Average Price represents the average price of a security over a particular time period (example one trading day) weighted by the volume traded at each price point.
52W H/L
This represents the 52 week high and low price of the security. It is also the 1 year high and low of the security. This represents the highest and lowest price touched by the security during the past 52 weeks or 1 year including today.
Aurobindo Pharma Ltd. shares drop 1.18% as Sensex falls
Share price of Aurobindo Pharma Ltd. falls as Nifty weakens
Share price of Aurobindo Pharma Ltd. rises as Nifty strengthens
Stock market update: Nifty Pharma index rises over 1%; Sun Pharma climbs over 2%
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
AnnouncementsInformation Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requi..
AnnouncementsEmployee & Interest Expense
Company has spent 1.32% of its operating revenues towards interest expenses and 13.94% towards employee cost in the year ending Mar 31, 2020. (Source: Consolidated Financials)Quarterly | Annual | Dec 2020 | Sep 2020 | Jun 2020 | Mar 2020 | Dec 2019 |
---|---|---|---|---|---|
Total Income | 6,498.31 | 6,537.19 | 6,040.37 | 6,191.02 | 5,925.93 |
Total Income Growth (%) | -0.59 | 8.22 | -2.43 | 4.47 | 5.42 |
Total Expenses | 2,458.96 | 5,307.97 | 4,922.95 | 5,062.37 | 4,950.01 |
Total Expenses Growth (%) | -53.67 | 7.82 | -2.75 | 2.27 | 4.95 |
EBIT | 4,039.35 | 1,229.22 | 1,117.42 | 1,128.65 | 975.92 |
EBIT Growth (%) | 228.61 | 10.01 | -0.99 | 15.65 | 7.86 |
Profit after Tax (PAT) | 2,946.46 | 806.23 | 780.58 | 849.83 | 705.45 |
PAT Growth (%) | 265.46 | 3.29 | -8.15 | 20.47 | 10.25 |
EBIT Margin (%) | 62.16 | 18.80 | 18.50 | 18.23 | 16.47 |
Net Profit Margin (%) | 45.34 | 12.33 | 12.92 | 13.73 | 11.90 |
Basic EPS (₹) | 50.29 | 13.75 | 13.32 | 14.50 | 12.04 |
All figures in Rs Cr, unless mentioned otherwise
Annual | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
---|---|---|---|---|---|
Total Assets | 28,926.35 | 26,454.36 | 21,101.04 | 16,249.42 | 15,920.20 |
Total Assets Growth (%) | 9.34 | 25.37 | 29.86 | 2.07 | 23.27 |
Total Liabilities | 12,115.83 | 12,561.99 | 9,418.80 | 6,875.43 | 8,630.35 |
Total Liabilities Growth (%) | -3.55 | 33.37 | 36.99 | -20.33 | 11.61 |
Total Equity | 16,810.52 | 13,892.37 | 11,682.24 | 9,373.99 | 7,289.85 |
Total Equity Growth (%) | 21.01 | 18.92 | 24.62 | 28.59 | 40.68 |
Current Ratio (x) | 1.44 | 1.28 | 1.41 | 1.39 | 1.31 |
Total Debt to Equity (x) | 0.32 | 0.49 | 0.38 | 0.33 | 0.61 |
Contingent Liabilities | 659.39 | 688.84 | 716.95 | 849.78 | 539.66 |
All figures in Rs Cr, unless mentioned otherwise
Decrease in Cash from Investing
Company has used Rs 1567.64 cr for investing activities which is an YoY decrease of 45.99%. (Source: Consolidated Financials)Annual | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
---|---|---|---|---|---|
Net Cash flow from Operating Activities | 4,381.28 | 1,650.97 | 1,954.52 | 3,278.58 | 1,419.76 |
Net Cash used in Investing Activities | -1,567.64 | -2,902.59 | -1,926.59 | -1,787.04 | -1,445.21 |
Net Cash flow from Financing Activities | -1,947.18 | 1,919.06 | 864.15 | -1,915.26 | 365.44 |
Net Cash Flow | 871.24 | 665.64 | 891.91 | -423.86 | 339.99 |
Closing Cash & Cash Equivalent | 2,746.82 | 1,875.58 | 1,209.94 | 319.63 | 743.80 |
Closing Cash & Cash Equivalent Growth (%) | 46.45 | 55.01 | 278.54 | -57.03 | 65.08 |
Total Debt/ CFO (x) | 1.24 | 4.09 | 2.29 | 0.94 | 3.11 |
All figures in Rs Cr, unless mentioned otherwise
Annual | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
---|---|---|---|---|---|
Return on Equity (%) | 16.84 | 17.02 | 20.74 | 24.55 | 27.78 |
Return on Capital Employed (%) | 23.31 | 23.82 | 26.66 | 32.37 | 37.12 |
Return on Assets (%) | 9.78 | 8.93 | 11.48 | 14.16 | 12.72 |
Interest Coverage Ratio (x) | 13.40 | 13.10 | 42.66 | 46.80 | 11.69 |
Asset Turnover Ratio (x) | 79.85 | 73.95 | 78.01 | 91.75 | 86.64 |
Price to Earnings (x) | 8.55 | 19.49 | 13.48 | 17.21 | 21.55 |
Price to Book (x) | 1.44 | 3.32 | 2.80 | 4.22 | 5.98 |
EV/EBITDA (x) | 5.30 | 12.38 | 9.26 | 11.87 | 13.92 |
EBITDA Margin (%) | 21.88 | 20.99 | 23.52 | 23.81 | 24.58 |
Bullish / Bearish signals for Aurobindo Pharma Ltd. basis selected technical indicators and moving average crossovers.
5 Day EMA Crossover
Bearish signal on daily chart
Appeared on: 4 Mar 2021
5D EMA: 875.80
Date | 7 days Gain/Loss % |
---|---|
11 Feb 2021 | -2.69% |
28 Jan 2021 | -5.88% |
15 Jan 2021 | -5.97% |
13 Jan 2021 | -1.94% |
Average price decline of -2.80% within 7 days of Bearish signal in last 5 years
10 Day EMA Crossover
Bearish signal on daily chart
Appeared on: 3 Mar 2021
10D EMA: 881.44
Date | 7 days Gain/Loss % |
---|---|
11 Feb 2021 | -2.69% |
28 Jan 2021 | -5.88% |
15 Jan 2021 | -5.97% |
21 Dec 2020 | -2.88% |
Average price decline of -3.08% within 7 days of Bearish signal in last 5 years
R1 | R2 | R3 | PIVOT | S1 | S2 | S3 | |
---|---|---|---|---|---|---|---|
Classic | 873.17 | 883.53 | 902.48 | 864.58 | 854.22 | 845.63 | 826.68 |
5 DAYS | 14 DAYS | 28 DAYS | |
---|---|---|---|
ATR | 21.11 | 26.27 | 28.87 |
Stock Returns vs Nifty 100
Stock gave a 3 year return of 42.33% as compared to Nifty 100 which gave a return of 42.14%. (as of last trading session)Stock Returns vs Nifty Pharma
Stock generated 42.33% return as compared to Nifty Pharma which gave investors 38.82% return over 3 year time period. (as of last trading session)Choose from Peers
Choose from Stocks
Stock Returns vs Nifty 100
Stock gave a 3 year return of 42.33% as compared to Nifty 100 which gave a return of 42.14%. (as of last trading session)Stock Returns vs Nifty Pharma
Stock generated 42.33% return as compared to Nifty Pharma which gave investors 38.82% return over 3 year time period. (as of last trading session)579.36
Amount Invested (in Cr.)
3.49%
% of AUM
-4.48
% Change (MoM basis)
492.54
Amount Invested (in Cr.)
2.05%
% of AUM
0.00
% Change (MoM basis)
452.62
Amount Invested (in Cr.)
10.78%
% of AUM
0.00
% Change (MoM basis)
MF Ownership as on 31 January 2021
Price
879.90-7.20 (-0.81%)
Open | High | Low | Prev Close | Contracts Traded | Turnover (₹ Lakhs) |
---|---|---|---|---|---|
881.05 | 889.50 | 872.55 | 887.10 | 2,628 | 15,071.76 |
Meeting Date | Announced on | Purpose | Details |
---|---|---|---|
Feb 10, 2021 | Feb 01, 2021 | Board Meeting | Quarterly Results & Interim Dividend |
Nov 11, 2020 | Nov 02, 2020 | Board Meeting | Quarterly Results & Interim Dividend |
Aug 27, 2020 | Aug 03, 2020 | AGM | Book closure from 25 Aug, 2020 to 27 Aug, 2020 |
Aug 12, 2020 | Aug 05, 2020 | Board Meeting | Quarterly Results & Interim Dividend |
Jun 03, 2020 | May 27, 2020 | Board Meeting | Audited Results |
Type | Dividend | Dividend per Share | Ex-Dividend Date | Announced on |
---|---|---|---|---|
Interim | 150% | 1.5 | Feb 22, 2021 | Feb 10, 2021 |
Interim | 125% | 1.25 | Nov 23, 2020 | Nov 11, 2020 |
Interim | 125% | 1.25 | Aug 21, 2020 | Aug 12, 2020 |
Interim | 175% | 1.75 | Feb 17, 2020 | Feb 06, 2020 |
Interim | 125% | 1.25 | Nov 21, 2019 | Nov 13, 2019 |
All Types | Ex-Date | Record Date | Announced on | Details |
---|---|---|---|---|
Bonus | Jul 20, 2015 | Jul 21, 2015 | May 28, 2015 | Bonus Ratio: 1 share(s) for every 1 shares held |
Splits | Feb 10, 2011 | Feb 11, 2011 | Nov 03, 2010 | Split: Old FV5.0| New FV:1.0 |
Splits | Oct 23, 2003 | Oct 31, 2003 | Aug 09, 2003 | Split: Old FV10.0| New FV:5.0 |
Bonus | Mar 07, 2000 | Apr 01, 2000 | Feb 22, 2000 | Bonus Ratio: 1 share(s) for every 1 shares held |
Bonus | Oct 26, 1998 | Nov 19, 1998 | Oct 08, 1998 | Bonus Ratio: 1 share(s) for every 1 shares held |
Aurobindo Pharma Ltd., incorporated in the year 1986, is a Large Cap company (having a market cap of Rs 50,554.78 Crore) operating in Pharmaceuticals sector. Aurobindo Pharma Ltd. key Products/Revenue Segments include Pharmaceuticals, Export Incentives, Sale of services and Scrap for the year ending 31-Mar-2020. Show More
Avnit Bimal Singh
Ind. Non-Executive DirectorB Adi Reddy
Co. Secretary & Compl. OfficerK Nithyananda Reddy
Vice Chairman & Whole Time DirK Ragunathan
Non Executive ChairmanIndustry
Key Indices Listed on
Nifty Next 50, Nifty 100, Nifty 200, + 23 more
Address
Plot No.2,Maitri Vihar,Ameerpet,Hyderabad, Telangana - 500038
Aurobindo Pharma Ltd. share price moved down by -1.38% from its previous close of Rs 874.90. Aurobindo Pharma Ltd. stock last traded price is 862.80
Share Price | Value |
---|---|
Today/Current/Last | 862.80 |
Previous Day | 874.90 |
DATA SOURCES: TickerPlant (for live BSE/NSE quotes service) and Dion Global Solutions Ltd. (for corporate data, historical price & volume, F&O data). Sensex & BSE Quotes and Nifty & NSE Quotes are real-time and licensed from BSE and NSE respectively. All timestamps are reflected in IST (Indian Standard Time).
DISCLAIMER: Any and all content on this website including tools/analysis is provided to you only for convenience and on an “as-is, as- available” basis without representation and warranties of any kind. The content and any output of such tools/analysis is for informational purposes only and should not be relied upon or construed as an investment advice or guarantee for any specific performance/returns advice or considered as recommendation for the purchase or sale of any security or investment. You are advised to exercise caution, discretion and independent judgment with regards to the same and seek advice from professionals and certified experts before taking any decisions.
By using this site, you agree to the Terms of Service and Privacy Policy.